Global Autoinjectors Market Research Report Insights and Industry Analysis by Product Type (Disposable, Reusable), Design (Customized, Standardized), by Therapeutic Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies) and Region, Competitive Market Size, Share, Trends, and Forecast, 2019-2024

Pune, India, June 13, 2019 (GLOBE NEWSWIRE) -- According to Market Research Future (MRFR), the global autoinjectors market is expected to witness significant growth at a compound annual growth rate of 17.42% over the forecast period of 2019 to 2024. Various factors are estimated to contribute to the growth, and the market is expected to reach a valuation of USD 79,741 million by 2024.

Autoinjectors are medical devices, often in the form of spring-loaded syringes, designed to deliver a dosage of a specific drug. Autoinjectors are preferred by medical professionals for their easy-to-use design and can be used by patients, or by untrained personnel.

The growth in global autoinjectors market is attributed to factors such as the increasing prevalence of targeted therapies, growing occurrence of health disorders such as anaphylaxis, asthma, and diabetes, among others.

Additionally, the growing technological advancements, and expenditure on the growth of the pharmaceutical, and biopharmaceutical sector are expected to contribute substantially to the growth of the market.

On the other hand, stringent regulatory policies are likely to hinder the market growth over the forecast period. However, the shifting focus of market players distribution of autoinjectors through on e-commerce has been assessed as a lucrative opportunity for market growth of autoinjectors.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/6311

Key Players

The key players identified in the global autoinjectors market are AbbVie Inc. (US), Amgen Inc. (US), Antares Pharma (US), Becton, Dickinson and Company (US), Consort Medical (UK), Eli Lilly and Company (US), Johnson & Johnson Services Inc. (US), Mylan N.V. (US), Owen Mumford Ltd (UK), SHL Group (Taiwan), Teva Pharmaceutical Industries Ltd (Israel), and Ypsomed (Switzerland).

Segmental Analysis

The global autoinjectors market has been segmented on the basis of product type, design, therapeutic application, distribution channel, and region.

Based on product type, the autoinjectors market has been segmented into disposable autoinjectors, and reusable autoinjectors. The disposable autoinjectors segment is expected to dominate the market, growing at the highest CAGR of 17.90% over the forecast period.

The segment is expected to grow due to the rising demand for the testing of new drugs and chemicals. Additionally, the dynamic growth in the pharmaceutical and biopharmaceutical industries is likely to contribute to market growth. These factors are expected to influence the segment market positively, and the segment is assessed to reach USD 53,696.20 million by the end of the forecast period.

Based on the design, the market has been segmented into customized autoinjectors and standardized autoinjectors.

Based on therapeutic application, the market has been segmented into anaphylaxis, diabetes, multiple sclerosis, rheumatoid arthritis, and others.

Based on the distribution channel, the autoinjectors market has been segmented into hospital pharmacies, retail pharmacies, and others.

North America Expected to Lead the market, followed by Europe

Based on the region, the market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas are the dominating region of the global Autoinjectors Market. This region is expected to sustain their leading market share, growing at a CAGR of 16.60% over the forecast period. Favorable factors, such as an established healthcare sector, technological advancements, and high investments, are likely to contribute to the market share.

Europe is the second largest region of the market and is likely to retain its position by exceeding a valuation of USD 24,307.74 million by 2024. The market in Europe is expected to grow, owing to the increasing prevalence of anaphylaxis, cancer, and diabetes. Additionally, the market players are focusing on research and development activities over the forecast period to introduce innovations to the drug delivery system.

Browse the market data and information spread across 130 pages with 121 data tables and 22 figures of the report “Autoinjectors Market- Forecast 2019-2024” in-depth alongside table of content (TOC) at: https://www.marketresearchfuture.com/reports/autoinjectors-market-6311

The Asia Pacific is assessed as the fastest-growing region of the market, at the highest growth rate of 18.95% over the forecast period. The market in the region is expecting to grow significantly owing to the focus of emerging economies in the region such as India, China, and Japan, on expanding their healthcare sector, which has led to an increase in the investments. The growing prevalence of diabetes and asthma in the region is expected to raise the demand for autoinjectors over the forecast period.

The Middle East and Africa region are expected to witness slow, gradual growth over the forecast period, register the smallest market share. This is attributed to the weak healthcare sector in Africa, with a lack of technological advancements and investments. The middle eastern countries such as Saudi Arabia, the United Arab Emirates, and Kuwait are expected to contribute the majority of the market share, owing to the better healthcare infrastructure.

Industry News

June 2019 – FDA approved two new self-administration options - autoinjector and pre-filled syringe, for GSK’s Nucala, which is used in severe eosinophilic asthma (SEA).

June 2019 – ZwickRoell announced their successful use of robotic technology in the testing of injectors, medicinal bottles, syringes, and injecting pens.

Make an Enquiry Before Buying this Report @ https://www.marketresearchfuture.com/enquiry/6311

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +16468459312
Email: sales@marketresearchfuture.com